对于青少年的避孕措施更新
Anna Carleen1, Ashley Ebersole1,2
1Nationwide Children's Hospital.
Current opinion in pediatrics
|April 2, 2025
概括
更新的指南和新的避孕方案使提供者能够提供以患者为中心的护理. 这包括为青少年和所有大小的人提供指导,促进非耻辱化的咨询.
科学领域:
- 生殖健康 生殖健康
- 避孕药是一种避孕药,用于避孕.
- 青少年医学 青少年医学
背景情况:
- 青少年避孕需要更新的指导和可访问的选择.
- 临床医生需要最新的信息来提供有效的,无耻感的咨询.
- 以患者为中心的护理对于多样化的人口来说至关重要.
研究的目的:
- 讨论针对青少年的最新避孕指南.
- 审查最近的避孕创新.
- 总结关于所有体型的脱的辅导的文献.
主要方法:
- 审查2024年美国选择性实践建议 (US SPR) 和美国适用避孕药的医疗资格 (US MEC) 准则.
- 关于新型避孕方法和患者经验的文学综合.
- 对避孕和体重管理的研究分析.
主要成果:
- 更新的美国SPR和美国MEC指导方针解决了各种健康状况和特定咨询需求.
- 较新的避孕药 (例如Annovera,Opill,Phexxi) 提供了独特的患者友好的功能.
- 研究正在扩大更广泛的BMI频谱的避孕安全性和有效性.
结论:
- 基于证据的指导方针和新型避孕方法提高了提供者提供以患者为中心护理的能力.
- 更新的建议支持患者的不同需求和偏好.
- 专注于脱的咨询和更广泛的包容性是必不可少的.
相关概念视频
Birth Control Methods
137
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
137
Hormonal Control of the Ovarian Cycle
344
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
344
Hormonal Regulation of the Menstrual Cycle
213
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
213
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Infertility in Females
226
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
226
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K


